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Summary: Choline acetyltransferase (EC 2.3.1.6) was studied in human cerebrospinal fluid and blood.
Sensitivity, precision and reproducibility of the radioactive assay were evaluated with a homogenate from pig
brain and with partially purified enzymes from bovine brain and human placenta. Contrary to other reports,
with the assay used in the present study, choline acetyltransferase activity was not detectable in the cerebro-
spinal fluid or blood of 50 patients with various neurological disorders. Only a very slight but significant
non-enzymatic formation of a radioactive product by concentrated cerebrospinal fluid was observed. Non-
enzymatic but enzyme-like formation of acetylcholine by thiol reagents and other compounds is discussed.
Introduction
So far, only a few attempts, with conflicting results,
have been made to detect choline acetyltransferase
activity in human cerebrospinal fluid and blood
(1 —3). As choline acetyltransferase is regarded to be
specifically localized in cholinergic neurons, its
changes in cerebrospinal fluid and serum might reflect
destruction of nervous tissue (4).
Previously, choline acetyltransferase activity was
termined preferentially by radipchemical methods.
Labeled acetylcholine is formed from labeled acetyl-
CoA and choline (5—7). The labeled product has to
be separated from the labeled substrate. This was
achieved by ion exchange chromatography, two phase
extraction and by combining both techniques. These
procedures are time consuming and cumbersome,
which may well explain the lack of investigations of
choline acetyltransferase activity in human body
fluids (4).
In 1975 Fonnum (8) published an improved method
for choline acetyltransferase measurement which in-
volves liquid cation exchange in a two-phase system
with direct counting. This is achieved by using the
toluene scintillation-mixture as an extraction solvent
and by carrying out the extraction directly in the
scintillation vial. This method was supposed to be
rapid, precise and sensitive (8). We considered it
worthwhile to attempt the detection of choline ace-
tyltransferase activity in cerebrospinal fluid and serum
with the improved method.
Materials and Methods
Chemicals
Choline bromide, eserine (physostigmine) and tetraphenylboron
were purchased from Sigma (München). EDTA (ethylenedini-
trilo) tetraacetic acid, sodium salt, (Titriplex III), acetonitrile,
toluene and salts for preparing buffers were purchased from
Merck (Darmstadt). Cibacron Blue F3GA (C. I. Reactive Blue,
Procion Blue H-BS) was purchased from Serva (Heidelberg).
Acetyl-Coenzyme A (acetyl-CoA) was purchased from Boeh-
ringer (Mannheim). Coenzyme A (acetyl-l-14C) acetyl (1.48
— 2.22 GBq/mmol) and Omnifiuor (pre-mixed LSC Powder)
were purchased from NEN (New England Nuclear, Dreieich).
Choline acetyltransferase partially purified from bovine brain
(lyophilized powder containing 5—20% protein) and from hu-
man placenta (suspension in 2.8 mol/1 (NH4)2SO4) were pur-
chased from Sigma (München).
Enzyme preparation
Whole pig brains from the slaughter house were placed on ice
within 30 min after death. All subsequent procedures were
carried out at 4 °C. After removal of the meninges and addition
of 1 1 extraction medium (phosphate-buffered saline pH 5.0),
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the brains (572g) were homogenized with an Ultra Turrax
(Janke & Kunkel, Staufen). The homogenate was centrifuged
(20 niin, 2500 g), the supernatant was discarded and the pellet
was dissolved in phosphate buffer pH 7.4 with Triton (5 g/1)
added. After centrifugation (20 min, 25000g) the pellet was
discarded and the supernatant brought to 60% saturation with
solid (NH4)2SO4, stirred for 30 min and centrifuged again (20
min, 25000^). The pellet was dissolved in 40 ml 50 mmol/1
sodium phosphate buffer pH 7.4 and dialysed overnight against
the same buffer with one change of buffer. The crude enzyme
preparation (pig brain) was then stored in aliquots below
-25°C.
Enzyme assay
Choline acetyltransferase activity was assayed according to the
method of Fonnum (8) with minor modifications. The final
volume of the reaction mixture was 10 μΐ containing 1,85 kBq
(50 nCi) [MC]acetyl CoA, 0.4 mmol/1 acetyl CoA, 300 mmol/1
sodium chloride, 50 mmol/1 sodium phosphate buffer pH 7.4,
8 mmol/1 choline bromide, 20 mmol/1 EDTA (pH 7.4) and 0.1
mmol/1 physostigmine. Enzyme solution (2.5 μΐ) was added to
the substrate solution (7.5 μΐ) in 0.5 ml Eppendorf tube. The
lubes were placed in a water bath at 22 °C or 37 °C. The reaction
was stopped after 10 min (if not stated otherwise) by addition
of 90 μΐ 10 mmol/1 sodium phosphate buffer pH 7.4. A total
of 100 μΐ was then transferred to a scintillation vial (20 ml)
containing 5ml 10 mmol/1 sodium phosphate buffer pH 7.4.
Acetonitriie (2ml) containing 10 mg tetraphenylboron was
added and after brief mixing, 10 ml toluene scintillation mixture
were then added. The vials were shaken slightly for 15 seconds
and the two phases were allowed to separate for 10 minutes
before counting.
Results and Discussion
To measure choline acetyltransferase activity the very
sensitive assay method of Fonnum (8) which is widely
accepted today (9) was adapted with minor modifi-
cations (see Material and Methods). This radioactive
assay involves three major steps: incubation of reac-
tion mixture, separation of radioactive product from
radioactive substrate and -counting. Each step has
to be controlled separately and in combination with
the other two. To make sure that the Fonnum assay
was working under optimal conditions we checked it
with enzyme standards from pig brain homogenates
(see Materials and Methods). In figure 1 the relation-
ship between product formation, amount of enzyme,,
time and temperature under optimal conditions is
shown. The typical decrease of the reaction velocity
of choline acetyltransferase after 20 min, due to en-
zyme inhibition by accumulation of free Coenzyme A
(6), is also depicted in figure 1. Measurements with
pig brain homogenates were found to be similar to
those with partially purified enzymes from human
placenta or bovine brain.
When testing choline acetyltransferase activity in
pooled fractions of cerebrospinal fluid and serum (10
patients each) we could not detect any formation of
radioactive acetylcholine, either in unboiled or boiled
samples (3). Tenfold concentrated body fluids also
showed no activity in the assay. Our results are thus,
at first glance, in contradiction to those of 1. c. (1—3).
These authors report extremely low amounts of ace-
tylcholine formed in cerebrospinal fluid. But Aquilo-
nius & Eckernas (3) suggested that about 95% of the
product measured was due to non-enzymatic conver-
sion of the substrate.
Due to these ambiguous results we studied choline
acetyltransferase activity in cerebrospinal fluid and
serum in more detail. When partially purified enzyme
from human placenta or bovine brain was added
either to cerebrospinal fluid, serum or phosphate
buffer, choline acetyltransferase activity stayed un-
changed at 4 °C for 7 days and at 22 °C for 24 hours
(data not shown). As choline acetyltransferase activity
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Fig. 1. Acetylcholine formation by pig brain homogenate in relation to time, amount of enzyme (parts of enzyme preparation)
and temperature as monitored by the Fonnum assay (see Materials and Methods) under optimal conditions The reaction
time was 10 min if not otherwise indicated. . .
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Fig. 2. Stability of choline acetyltransferase
a) Incubation of enzyme from human placenta in phosphate buffer at 0 °C — o—, 22 °C — —, 37 °C — o —.
b) Incubation of enzyme from pig brain — o —, bovine brain — A —, and human placenta — o— in serum at 37 °C.
c) Incubation of enzyme from human placenta in cerebrospinal fluid with dithiothreitol (1 mmol/1) — o— and without
dithiothreitol -o— at 37 °C.
at 0 °C, 22 °C, and 37 °C for 1 hour and recorded
choline acetyltransferase activity every 15 minutes. A
sharp decline of choline acetyltransferase is noticed
(fig. 2 a) at 37 °C. This applies particularly to serum
and cerebrospinal fluid (data not shown). The decline
of enzyme activity is fastest for human placenta fol-
lowed by bovine brain and pig brain (fig. 2b). The
degree of acetyltransferase inactivation is thus due to
the matrix (serum, cerebrospinal fluid or buffer) and
to the source of enzyme. When using preheated
(70 °C, 30 min) body fluids the decrease of choline
acetyltransferase did not alter. Thus, the biological
inactivation of acetyltransferase (e.g. by proteases)
can be ruled out.
We noticed then that pig brain homogenates prepared
by addition of thiol reagents (ß-mercaptoethanol or
dithiothreitol) were less or not at all affected in the
experiments described above. Thiol reagents are reg-
ularly used in choline acetyltransferase purification
procedures to stabilize the enzyme (10, 11). When
thiol reagents (e. g. l mmol/1 dithiothreitol) are added
to serum or cerebrospinal fluid before the enzyme the
decrease of activity is completely stopped as shown
in figure 2 c. From this result we draw the conclusion
that some labile thiol groups of the enzyme (10, 12)
will be oxidized chemically in body fluids at 37 °C if
not protected sufficiently by addition of a thiol re-
agent. This suggestion is in good accord with the fast
decline of enzyme activtiy immediately after incuba-
tion (fig. 2). Inactivation of choline acetyltransferase
in body fluids may be explained in this way. The
various degrees of inactivation that occurred with the
partually purified enzymes from different species may
be explained by different quantities and qualities of
inherent protecting factors. It is well known (12, 9)
that choline acetyltransferase becomes more and more
labile during purification if thiol reagents are not
added.
We do not know whether acetyltransferase inherent
in body fluids — if existing at all — will be protected
from autoxidation. Addition of thiol reagents to body
fluids immediately after tapping in order to stabilize
inherent choline acetyltransferase seems not advisable
because thiol reagents themselves produce choline ace-
tyltransferase-like activity in the Fonnum assay as
shown in figure 3. This fact has to our knowledge not
been described to date in the literature. The choline
acetyltransferase-like activity depends linearly on the
amount of thiol reagent and the reaction time (fig.
3). As Roskoski et al. (12) suggest, an acetyl-thioen-
zyme may be involved as an intermediate in the cho-
line acetyltransferase reaction mechanism. It seems
that thiol reagents may replace this intermediate by
possible forming an acetyl thio-compound. The latter
has not been characterized. Acetyltransferase-like ac-
tivity was low when 1 mmol/1 or less thiol reagent was
used (fig. 3), and therefore it was negligible in the
experiments described above where high amounts of
enzyme activity were added to the body fluids. But
thiol reagents will cause serious problems if traces of
inherent choline acetyltransferase activity are to be
measured. The minimum amount of dithiothreitol for
stabilizing choline acetyltransferase (human placenta)
in cerebrospinal fluid during 20 min is 0.1 mmol/1.
Even this amount produces measurable quantities of
radioactive acetylcholine (fig. 4).
In the following investigations the body fluids were
cooled to 4 °C or frozen at —25 °C immediately after
veni or lumbar puncture of the patients. Before testing
choline acetyltransferase activity in cerebrospinal
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Fig. 3. Non-enzymatic acetylcholine formation in the presence
of dithiothreitol in relation to its concentration and the
reaction time (insert, 5 mmol/1). In the Fonnum assay
(see Materials and Methods) the enzyme sample was
replaced by a solution of dithiothreitol.
Fig. 4. Stability of choline acetyltransferase of human placenta
in cerebrospinal fluid with various amounts of dithio-
threitol added. 1 mmol/1 -Δ-, 0.1 mmol/1 -o-, or
0.01 mmol/1 -o-. Insert: choline acetyltransferase like
activity caused by 1 ml of 0.1 mmol/1 dithiothreitol.
fluid, the samples were concentrated tenfold as re-
ported by other authors (1, 3), using a Speed Vac
apparatus (Savant) which evaporates the solvent un-
der vacuum while rotating the samples. All solvents
will be concentrated equally. This technique is thought
to be mild. But when choline acetyltransferase was
added before concentration the recovery of activity
was only about 20% of the calculated tenfold aug-
mented value, which in turn was only twice that of.
the unconcentrated fluid. Inactivation and denatura-
tion of proteins during concentration is a well known
phenomenon of protein biochemistry (13). Comparing
Speed Vac concentration with Centriflow filters (Ami-
con) — retention limit Μτ 25000 — the recovery of
acetyltransferase activity was even worse. The useful^
ness of concentrating eerebrospinal fluid in order to
detect choline acetyltransferase activity seems to be
limited.
Cerebrospinal fluid and serum samples from 50 con-
secutive patients were studied for choline acetyltrans-
ferase activity under conditions just characterized.
Each sample, unconcentrated and tenfold concen-
trated, was tested at 22 °C and at 37 °C for 10 and
20 min. None of the samples really showed an enzyme-
like reaction. A very faint but significant increase in
radioactive acetylcholine could be observed at 37 °C
with the concentrated samples (start: 205 ± 41, after
20 min: 248 ± 41 nmol/1 · min, n = 50). This low
product formation was never found with serum or
with blanks. The values measured were in the range
of those found by Aquilonius & Eckernas (3), Johnson
& Domino (1), Rimon et al. (2). To check the possibility
of an extremely faint enzymatic activity we therefore
performed experiments to compare heated and un^
heated samples of cerebrospinal fluid with those in-
hibited with Cibacron Blue. Cibacron Blue is a potent
inhibitor of choline acetyltransferase (12). In this ex-
periment all samples except blanks show a similar
increase in radioactivity (fig. 5). This result indicates
a very low non-enzymatic formation of product. Cho-
line acetyltransferase activity in cerebrospinal fluid
described in the past may fall into this category. As
20
Fig. 5. Acetylcholine formation by cerebrospinal fluid. Blank
(phosphate buffer, pH 7.4) — o—, unboiled — ο—,
boiled ^A —. Cibacron Blue inhibited cerebrospinal
fluid — Q—, serum —D —. * ?
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Aquilonius & Eckernas (3) have already pointed out,
non-enzymatic formation of acetylcholine is possible,
e. g. by imidazole. As we have shown, it is also possible
by thiol reagents.
In conclusion no measurable amounts of choline ace-
tyltransferase activity can be determined in human
cerebrospinal fluid or serum with the very sensitive
assay of Fonnwn (detection limit, 0.5 — 1.0 /
1 · min acetylcholine formation). There is thus a chal-
lenge to develop new methods based on immuno
techniques, which will be capable of detecting traces
of choline acetyltransferase molecules, even if the
enzyme is inactivated.
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